Cornelius · MMWR. Morbidity and mortality weekly report 2022 · cross-sectional survey · n=?

Tobacco Product Use Among Adults - United States, 2020.

Cited 730 times in the scientific literature.

Level 4 - case-series / case-control

Cross-sectional national survey (by design analogy, non-clinical CEBM)

PubMed 35298455 · doi:10.15585/mmwr.mm7111a1 · record verified 2026-08-29

What was done

CDC analyzed data from the 2020 National Health Interview Survey (NHIS) to assess national estimates of commercial tobacco product use (cigarettes, e-cigarettes, cigars, smokeless tobacco, pipes) among U.S. adults aged 18 years or older.

What was found

In 2020, 19.0% of U.S. adults (estimated 47.1 million) reported current commercial tobacco product use: cigarettes (12.5%), e-cigarettes (3.7%), cigars (3.5%), smokeless tobacco (2.3%), and pipes (1.1%). Among current users, 79.6% used combustible products and 17.3% used two or more products. From 2019 to 2020, overall tobacco use, combustible use, cigarettes, e-cigarettes, and polytobacco use decreased. Prevalence was higher among men, adults aged <65 years, non-Hispanic American Indian/Alaska Native and 'Other' race adults, rural residents, GED holders, individuals with household income <$35,000, lesbian/gay/bisexual adults, uninsured/Medicaid recipients, adults with disabilities, and individuals with regular feelings of anxiety or depression.

Why it matters

Provides updated national surveillance on tobacco use trends and highlights persistent demographic and socioeconomic disparities requiring targeted intervention strategies.

Limits

The total sample size (n) is not reported in the abstract. Data rely entirely on self-reported commercial tobacco use rather than biochemical validation, and the cross-sectional design cannot establish causality or individual trajectories over time.

Cited by